Chronic Obstructive Pulmonary Disease (COPD)
COPD affects thirty million Americans and is a major consequence of environmental exposures to toxins, particularly tobacco smoking. We have found that in rodents exposed to daily tobacco smoke, the deterioration of lung structure and function due to COPD can be markedly decreased by repetitive intravenous therapy with adipose stem cells. We also have early data that suggests that the degree of COPD can be lessened by these cells. We are working to arrange for an initial clinical trial to evaluate this possibility in patients with COPD.